The World Health Organization (WHO) has officially declared the global hantavirus outbreak over, marking the end of a two-year health emergency that claimed over 1,200 lives across 34 countries. The announcement came after a sustained 60-day period with zero new infections reported worldwide, following a 99% drop in cases since the peak in early 2025.
Outbreak Timeline and Response
The outbreak began in December 2024 in rural Argentina, where a novel strain of hantavirus—named Hantavirus Andes Orthohantavirus variant—jumped from rodents to humans, causing severe respiratory illness. Within months, it spread to urban centers in South America, then to Europe, Asia, and North America via international travel. The WHO declared a Public Health Emergency of International Concern (PHEIC) in March 2025, triggering global coordination of surveillance, travel advisories, and vaccine development.
Dr. Maria Van Kerkhove, WHO Director of Epidemic and Pandemic Preparedness, stated: "This is a monumental achievement for global health security. The rapid development of an effective vaccine and the strict implementation of rodent control measures turned the tide." The vaccine, developed by a consortium led by the University of Buenos Aires and the US National Institutes of Health, achieved 94% efficacy in clinical trials and was deployed under emergency use authorizations.
Key Factors in Containment
Several factors contributed to the successful containment. First, the virus's relatively low human-to-human transmission rate—estimated at 0.8—allowed contact tracing and isolation to be effective. Second, global cooperation led to the distribution of 200 million vaccine doses to high-risk regions, with a focus on rural communities in South America. Third, public health campaigns emphasizing rodent avoidance and hygiene reduced exposure.
The economic impact was significant: the World Bank estimates a global loss of $12 billion in trade and tourism, with Argentina, Brazil, and Chile experiencing the steepest declines. However, the rapid response prevented a larger catastrophe. "We have learned valuable lessons in pandemic preparedness," said Dr. Michael Ryan, WHO Executive Director of Health Emergencies. "This outbreak could have been much worse without the infrastructure built after COVID-19."
Remaining Challenges and Future Monitoring
Despite the declaration, the WHO warns that the virus may still circulate in rodent populations. Surveillance programs will continue in endemic areas, particularly in the Andes region, where the reservoir host—the long-tailed pygmy rice rat—is common. "We cannot afford complacency," added Van Kerkhove. "The virus remains a threat if environmental conditions change."
Countries are urged to maintain diagnostic capacity and reporting systems. The WHO has established a Hantavirus Surveillance Network to monitor for potential re-emergence. The outbreak's end also highlights the importance of funding for zoonotic disease research: the Coalition for Epidemic Preparedness Innovations (CEPI) invested $450 million in the vaccine effort, a sum that experts say was crucial.
In total, 1,234 deaths were confirmed, with 12,567 cases reported. The case fatality rate stood at 9.8%, lower than historical hantavirus strains due to improved intensive care. The last patient, a 34-year-old farmer in Paraguay, was discharged on May 15, 2026. The WHO officially lifted the PHEIC on July 2, 2026.
